Centene Corporation (CNC) - Stock Analysis
Last updated: Jun 7, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin rebound ⢠Strong cash flow ⢠Debt burden CNC's 2025 loss masks a sharp Q1 2026 recovery, with stronger margins and solid cash generation supporting liquidity, though high leverage and thin current coverage remain key risks.
Price Behavior
Key Price Behavior Insights: ⢠Higher highs ⢠Key support hold ⢠Near-term resistance Support Level: $58.80-$59.60 Resistance Level: $62.70 CNC has been in a constructive uptrend over the last month, holding roughly $58.80-$59.60, but it still needs a decisive break above $62.70 to confirm more upside and avoid near-term consolidation.
Sentiment & News
Key News Insights: ⢠Analyst support ⢠Post-earnings strength ⢠Service quality Centene is seeing sustained analyst support as a value/growth pick, with recent post-earnings strength and positive service/community headlines reinforcing a constructive near-term outlook.
AI Summary
Centene has moved from a speculative turnaround to a durability test: the recent margin and earnings rebound supports a re-rating, but with Medicaid medical-cost pressure and regulatory risk still high, the stock now depends on several more clean quarters to justify its run-up.
Description
Centene Corporation is a multinational healthcare company that provides programs and services primarily for under-insured and uninsured individuals in the U.S., delivering government-funded managed care across Medicaid, CHIP, long-term services and supports, foster care, and plans for dually eligible and disabled populations, alongside commercial insurance products. Its offerings span clinical and non-clinical care coordination, pharmacy and behavioral health services, telehealth and home-based care, and supplemental services for vision, dental and transportation; a separate specialty-services unit provides pharmacy benefits management, nurse advice lines, correctional and military health support, and related staffing. The company was founded in 1984 and is headquartered in St. Louis, Missouri.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CNC | Centene Corporation | Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment. | Closed | +6.9% |